Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID).
暂无分享,去创建一个
S. Cooray | M. Crawford | P. Tyrer | M. Knapp | S. Bhaumik | D. Harley | B. Rao | K. Kramo | P. Oliver-Africano | Z. Ahmed | N. Bouras | M. Hare | B. Reece | A. Regan | B. North | J. Eliahoo | S. Karatela | R. Romeo | M. Meade | A. Soni | J. Watson | L. Lenôtre | D. Murphy | S. Dickens | S. Deb | D. Thomas | Shamshad Karatela | Zed Ahmed | Ben Reece | Kofi Kramo | James E. M. Watson | Nick Bouras | Martin Knapp | Michael Meade | David Harley | Adrienne Regan | Peter Tyrer | Mike J. Crawford | Renee Romeo | Sanjukta Deb | Declan G. Murphy | David L. Thomas | Anju Soni | Bernard V. North | Patricia C Oliver-Africano
[1] L. Curtis,et al. Unit Costs of Health and Social Care 2016 , 2015 .
[2] D. Branford. A study of the prescribing for people with learning disabilities living in the community and in National Health Service care. , 2008, Journal of intellectual disability research : JIDR.
[3] D. Clarke,et al. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings. , 2008, Journal of mental deficiency research.
[4] M. Pitt,et al. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. , 2008, Health technology assessment.
[5] D. Murphy,et al. Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial , 2008, The Lancet.
[6] D Elbourne,et al. Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. , 2007, Health technology assessment.
[7] M. Crawford,et al. Modified Overt Aggression Scale (MOAS) for People with Intellectual Disability and Aggressive Challenging Behaviour: A Reliability Study , 2007 .
[8] R. Poole,et al. Influence of drug company authorship and sponsorship on drug trial outcomes. , 2007, The British journal of psychiatry : the journal of mental science.
[9] P. Jones,et al. Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy. , 2007, The British journal of psychiatry : the journal of mental science.
[10] Peter Tyrer,et al. Comparison of alternative methods of collection of service use data for the economic evaluation of health care interventions. , 2007, Health economics.
[11] Daniel Polsky,et al. Economic Evaluation in Clinical Trials , 2007 .
[12] P. Tyrer,et al. Nidotherapy in practice , 2007 .
[13] S. Cooper,et al. Mental ill-health in adults with intellectual disabilities: prevalence and associated factors , 2007, British Journal of Psychiatry.
[14] D. Symmons,et al. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling. , 2006, Health technology assessment.
[15] Robert Jones,et al. Practitioner consensus in the use of cognitive behaviour therapy for individuals with a learning disability , 2006, Journal of intellectual disabilities : JOID.
[16] S. Paisley,et al. Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation. , 2006, Health technology assessment.
[17] E. Kaltenthaler,et al. COMPUTERISED COGNITIVE BEHAVIOUR THERAPY FOR DEPRESSION AND ANXIETY , 2002 .
[18] Jennifer A. Roberts,et al. Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. , 2006, Health technology assessment.
[19] R. Murray,et al. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. , 2006, Health technology assessment.
[20] Simon Finfer,et al. SAFE (The Saline versus Albumin Fluid Evaluation) 試験 , 2006 .
[21] M. Pitt,et al. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. , 2006, Health technology assessment.
[22] Stephen Palmer,et al. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation. , 2006, Health technology assessment.
[23] C. Clar,et al. Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. , 2005, Health technology assessment.
[24] C. Bull,et al. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. , 2005, Health technology assessment.
[25] M. Pitt,et al. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. , 2005, Health technology assessment.
[26] M. Sculpher,et al. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis. , 2005, Health technology assessment.
[27] J. Lieberman,et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.
[28] D. Symmons,et al. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. , 2005, Health technology assessment.
[29] D. Lamping,et al. An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales. , 2005, Health technology assessment.
[30] R Garside,et al. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. , 2005, Health technology assessment.
[31] D G Altman,et al. Indirect comparisons of competing interventions. , 2005, Health technology assessment.
[32] Martin Knapp,et al. A comparison of two methods of collecting economic data in primary care. , 2005, Family practice.
[33] J Raftery,et al. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. , 2005, Health technology assessment.
[34] M Sculpher,et al. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. , 2005, Health technology assessment.
[35] C Fraser,et al. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation. , 2005, Health technology assessment.
[36] C. Beverley,et al. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies. , 2005, Health technology assessment.
[37] P Barton,et al. Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK. , 2005, Health technology assessment.
[38] M Knapp,et al. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. , 2005, Health technology assessment.
[39] A. Grant,et al. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions. , 2005, Health technology assessment.
[40] C. Fowler,et al. Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia. , 2005, Health technology assessment.
[41] L. Thorpe,et al. Short- and long-term efficacy and safety of risperidone in adults with disruptive behavior disorders , 2005, Psychopharmacology.
[42] P Wainwright,et al. Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations. , 2004, Health technology assessment.
[43] A. Silman,et al. Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis. , 2004, Health technology assessment.
[44] S. Ebrahim,et al. Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups. , 2004, Health technology assessment.
[45] N. Waugh,et al. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation. , 2004, Health technology assessment.
[46] M Sculpher,et al. Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation. , 2004, Health technology assessment.
[47] A Haycox,et al. Coronary artery stents: a rapid systematic review and economic evaluation. , 2004, Health technology assessment.
[48] M. Mugford,et al. The Social Support and Family Health Study: a randomised controlled trial and economic evaluation of two alternative forms of postnatal support for mothers living in disadvantaged inner-city areas. , 2004, Health technology assessment.
[49] A. Round,et al. Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis. , 2004, Health technology assessment.
[50] S. Mason,et al. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. , 2004, Health technology assessment.
[51] J. Dretzke,et al. Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus. , 2004, Health technology assessment.
[52] Anita Patel,et al. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care , 2004, International clinical psychopharmacology.
[53] M Sculpher,et al. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. , 2004, Health technology assessment.
[54] J Gabbay,et al. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. , 2004, Health technology assessment.
[55] A. Thompson,et al. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. , 2004, Health technology assessment.
[56] K. Morgan,et al. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. , 2004, Health technology assessment.
[57] M. Westwood,et al. Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer. , 2004, Health technology assessment.
[58] B. Cooper,et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. , 2003, Health technology assessment.
[59] T. Sensky,et al. Principles of Nidotherapy in the Treatment of Persistent Mental and Personality Disorders , 2003, Psychotherapy and Psychosomatics.
[60] D. Janowsky,et al. Effects of Topiramate on Aggressive, Self-Injurious, and Disruptive/Destructive Behaviors in the Intellectually Disabled: An Open-Label Retrospective Study , 2003, Journal of clinical psychopharmacology.
[61] F. Song,et al. Evaluating non-randomised intervention studies. , 2003, Health technology assessment.
[62] P. Roderick,et al. The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model. , 2003, Health Technology Assessment.
[63] O. Ukoumunne. A comparison of confidence interval methods for the intraclass correlation coefficient in cluster randomized trials , 2002, Statistics in medicine.
[64] L. Sandler. Risperidone in children with autism and serious behavioral problems. , 2002, The New England journal of medicine.
[65] N. Waugh,et al. Screening for gestational diabetes: a systematic review and economic evaluation. , 2002, Health technology assessment.
[66] S. Wessely,et al. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. , 2002, Health technology assessment.
[67] R. Novaco,et al. Cognitive-behavioural treatment of anger intensity among offenders with intellectual disabilities , 2002 .
[68] David R. Jones,et al. A systematic review of discharge arrangements for older people. , 2002, Health technology assessment.
[69] S. Cooray,et al. Difficulties in conducting a randomized controlled trial of health service interventions in intellectual disability: implications for evidence-based practice. , 2002, Journal of intellectual disability research : JIDR.
[70] E Berry,et al. The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review. , 2002, Health technology assessment.
[71] H. Costello,et al. Reliability and validity of the Mini PAS-ADD for assessing psychiatric disorders in adults with intellectual disability. , 2002, Journal of intellectual disability research : JIDR.
[72] C. McDougle,et al. Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism. , 2001, Journal of child and adolescent psychopharmacology.
[73] C. Czoski-Murray,et al. Extended scope of nursing practice: a multicentre randomised controlled trial of appropriately trained nurses and pre-registration house officers in pre-operative assessment in elective general surgery. , 2001, Health technology assessment.
[74] P. Garthwaite,et al. Statistical assessment of the learning curves of health technologies. , 2001, Health technology assessment.
[75] S. Gray,et al. Barriers to participation in randomised controlled trials. , 2001, Journal of clinical epidemiology.
[76] A Briggs,et al. Economic evaluation and clinical trials: size matters , 2000, BMJ : British Medical Journal.
[77] M. Mugford,et al. Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views. , 2000, Health technology assessment.
[78] P. Sandercock,et al. Framework for design and evaluation of complex interventions to improve health , 2000, BMJ : British Medical Journal.
[79] W. Fraser. Three decades after Penrose , 2000, British Journal of Psychiatry.
[80] R. Prescott,et al. Barriers to participation in randomised controlled trials: a systematic review. , 1999, Journal of clinical epidemiology.
[81] A. Glenny,et al. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials , 1998, Health technology assessment.
[82] M J Al,et al. Sample size calculation in economic evaluations. , 1998, Health economics.
[83] A. Mortimer,et al. Prospective study into factors associated with aggressive incidents in psychiatric acute admission wards , 1998, British Journal of Psychiatry.
[84] S. Cooper,et al. Prevalence and Cluster Typology of Maladaptive Behaviours in a Geographically Defined Population of Adults with Learning Disabilities , 1996, British Journal of Psychiatry.
[85] D. Reeves,et al. The use of anti-psychotic drugs with adults with learning disabilities and challenging behaviour. , 1995, Journal of intellectual disability research : JIDR.
[86] J. Peuskens. Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol , 1995, British Journal of Psychiatry.
[87] M. Aman,et al. Factor validity and norms for the Aberrant Behavior Checklist in a community sample of children with mental retardation , 1992, Journal of autism and developmental disorders.
[88] Douglas G. Altman,et al. Practical statistics for medical research , 1990 .
[89] O. Linaker. Frequency of and Determinants for Psychotropic Drug Use in an Institution for the Mentally Retarded , 1990, British Journal of Psychiatry.
[90] R. Pruchno. The Effects of Help Patterns on the Mental Health of Spouse Caregivers , 1990, Research on aging.
[91] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[92] U. Ahlfors,et al. The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients , 1987, Acta psychiatrica Scandinavica. Supplementum.
[93] M. Aman,et al. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. , 1985, American journal of mental deficiency.
[94] L. Hollister,et al. Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital. , 1960, The American journal of psychiatry.
[95] H. Bair,et al. Efficacy of chlorpromazine in hyperactive mentally retarded children. , 1955, A.M.A. archives of neurology and psychiatry.
[96] G. ter Riet,et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. , 2008, Health technology assessment.
[97] S. Deb,et al. Using medication to manage behaviour problems among adults with a learning disability , 2006 .
[98] P. Willner. The effectiveness of psychotherapeutic interventions for people with learning disabilities: a critical overview. , 2005, Journal of intellectual disability research : JIDR.
[99] H. Williams,et al. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. , 2005, Health technology assessment.
[100] R. Collins,et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. , 2005, Health technology assessment.
[101] C. Normand,et al. A systematic review of the role of bisphosphonates in metastatic disease. , 2004, Health technology assessment.
[102] M K Campbell,et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. , 2004, Health technology assessment.
[103] P F Sharp,et al. The value of digital imaging in diabetic retinopathy. , 2003, Health technology assessment.
[104] David R. Jones,et al. A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma. , 2003, Health technology assessment.
[105] J Cowan,et al. Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation. , 2003, Health technology assessment.
[106] T P Klassen,et al. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. , 2003, Health technology assessment.
[107] P. Royle,et al. Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system. , 2003, Health technology assessment.
[108] J. Wight,et al. Treatments for spasticity and pain in multiple sclerosis: a systematic review. , 2003, Health technology assessment.
[109] J Chilcott,et al. A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative. , 2003, Health technology assessment.
[110] A Haycox,et al. Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. , 2003, Health technology assessment.
[111] S. Stearns,et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. , 2003, Health technology assessment.
[112] A. Grant,et al. Systematic review of the clinical effectiveness and cost-effectiveness of tension-free vaginal tape for treatment of urinary stress incontinence. , 2003, Health technology assessment.
[113] A. Bagnall,et al. Effectiveness and cost-effectiveness of acute hospital-based spinal cord injuries services: systematic review. , 2003, Health technology assessment.
[114] S. Paisley,et al. Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review. , 2003, Health technology assessment.
[115] S. Eckstein. The ethical conduct of research on the mentally incapacitated , 2003 .
[116] K. Payne,et al. Which anaesthetic agents are cost-effective in day surgery? Literature review, national survey of practice and randomised controlled trial. , 2002, Health technology assessment.
[117] J A Kanis,et al. Treatment of established osteoporosis: a systematic review and cost-utility analysis. , 2002, Health technology assessment.
[118] R. Milne,et al. Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. , 2002, Health technology assessment.
[119] R. Milne,et al. Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. , 2002, Health technology assessment.
[120] S. Bryan,et al. Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. , 2002, Health technology assessment.
[121] P. Royle,et al. Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice. , 2002, Health technology assessment.
[122] G. Goodwin,et al. Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials. , 2001, The British journal of psychiatry. Supplement.
[123] T. Skinner,et al. Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. , 2001, Health technology assessment.
[124] P. Barry,et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. , 2001, Health technology assessment.
[125] M. Knapp,et al. Home treatment for mental health problems: a systematic review. , 2001, Health technology assessment.
[126] R. Fitzpatrick,et al. Issues in methodological research: perspectives from researchers and commissioners. , 2001, Health technology assessment.
[127] C. Eiser,et al. Quality-of-life measures in chronic diseases of childhood. , 2001, Health technology assessment.
[128] T. Peters,et al. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. , 2001, Health technology assessment.
[129] P. Whiting,et al. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention. , 2001, Health technology assessment.
[130] S. Walters,et al. Costs and benefits of community postnatal support workers: a randomised controlled trial. , 2000, Health technology assessment.
[131] M. McDonagh,et al. A rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer. , 2000, Health technology assessment.
[132] K Tolley,et al. The effectiveness of domiciliary health visiting: a systematic review of international studies and a selective review of the British literature. , 2000, Health technology assessment.
[133] F. Cowan,et al. Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness. , 2000, Health technology assessment.
[134] Williams Je,et al. Intrathecal pumps for giving opioids in chronic pain: a systematic review. , 2000, Health technology assessment.
[135] A. Culyer,et al. False-negative results in screening programmes: systematic review of impact and implications. , 2000, Health technology assessment.
[136] K. Jolly,et al. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. , 2000, Health technology assessment.
[137] E Berry,et al. Intravascular ultrasound-guided interventions in coronary artery disease: a systematic literature review, with decision-analytic modelling, of outcomes and cost-effectiveness. , 2000, Health technology assessment.
[138] P. Bower,et al. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care. , 2000, Health technology assessment.
[139] M. Gulliford,et al. Monitoring blood glucose control in diabetes mellitus: a systematic review. , 2000, Health technology assessment.
[140] R. Milne,et al. Disease-modifying drugs for multiple sclerosis: a rapid and systematic review. , 2000, Health technology assessment.
[141] C. Normand,et al. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. , 2000, Health technology assessment.
[142] Ann Netten,et al. Unit Costs of Health and Social Care 2002 , 2000 .
[143] N. Waugh,et al. Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review. , 2000, Health technology assessment.
[144] M. McDonagh,et al. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina. , 2000, Health technology assessment.
[145] A. Culyer,et al. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. , 2000, Health technology assessment.
[146] David R. Jones,et al. Bayesian methods in health technology assessment: a review. , 2000, Health technology assessment.
[147] A. Culyer,et al. Liquid-based cytology in cervical screening: a rapid and systematic review. , 2000, Health technology assessment.
[148] R. Jordan,et al. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. , 2000, Health technology assessment.
[149] D. Ashby,et al. An introduction to statistical methods for health technology assessment. , 2000, Health technology assessment.
[150] Fraser Wi. Three decades after Penrose. , 2000 .
[151] T. Sheldon,et al. What role for statins? A review and economic model. , 1999, Health technology assessment.
[152] E. A. Nelson,et al. Systematic reviews of wound care management: (2). Dressings and topical agents used in the healing of chronic wounds. , 1999, Health technology assessment.
[153] A. Glenny,et al. Antimicrobial prophylaxis in total hip replacement: a systematic review. , 1999, Health technology assessment.
[154] J Gabbay,et al. 'Early warning systems' for identifying new healthcare technologies. , 1999, Health technology assessment.
[155] A. Culyer,et al. A systematic literature review of spiral and electron beam computed tomography: with particular reference to clinical applications in hepatic lesions, pulmonary embolus and coronary artery disease. , 1999, Health technology assessment.
[156] David R. Jones,et al. Methods for the analysis of quality-of-life and survival data in health technology assessment. , 1999, Health technology assessment.
[157] A E Ades,et al. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. , 1999, Health technology assessment.
[158] A. Culyer,et al. Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews. , 1998, Health technology assessment.
[159] M. Smith,et al. Systematic review of endoscopic ultrasound in gastro-oesophageal cancer. , 1998, Health Technology Assessment.
[160] M J Buxton,et al. Evaluating patient-based outcome measures for use in clinical trials. , 1998, Health technology assessment.
[161] M. Petticrew,et al. Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions. , 1998, Health technology assessment.
[162] R. Moore,et al. Postoperative analgesia and vomiting, with special reference to day-case surgery: a systematic review. , 1998, Health technology assessment.
[163] E. Murphy,et al. Qualitative research methods in health technology assessment: a review of the literature. , 1998, Health technology assessment.
[164] D. Spiegelhalter,et al. Consensus development methods, and their use in clinical guideline development. , 1998, Health technology assessment.
[165] J A Brebner,et al. When and how to assess fast-changing technologies: a comparative study of medical applications of four generic technologies. , 1997, Health technology assessment.
[166] A. Culyer,et al. Newborn screening for inborn errors of metabolism: a systematic review. , 1997, Health technology assessment.
[167] M Forshaw,et al. A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment. , 1997, Health technology assessment.
[168] J Nicholl,et al. Routine preoperative testing: a systematic review of the evidence. , 1997, Health technology assessment.
[169] A. Knowles. DIABETIC FOOT ULCERATION , 1996 .
[170] S. Cohen,et al. Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance. , 1996, Psychopharmacology bulletin.
[171] J. Mansell,et al. Severe Learning Disabilities and Challenging Behaviours: Designing high quality services , 1994 .
[172] M. Reichman,et al. Rating aggression in the clinical setting. A retrospective adaptation of the Overt Aggression Scale: preliminary results. , 1991, The Journal of neuropsychiatry and clinical neurosciences.
[173] S. Yudofsky,et al. The Overt Aggression Scale: overview and guiding principles. , 1991, The Journal of neuropsychiatry and clinical neurosciences.
[174] C. Gutheil,et al. The measurement of aggressive behavior: reflections on the use of the Overt Aggression Scale and the Modified Overt Aggression Scale. , 1991, The Journal of neuropsychiatry and clinical neurosciences.
[175] J. Endicott,et al. The Overt Aggression Scale for the objective rating of verbal and physical aggression. , 1986, The American journal of psychiatry.
[176] S. Rothman,et al. The Willowbrook Wars , 1984 .